Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Ordinary Shares, par value GBP 0.003 per share · CUSIP: 589492107

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Northpond Ventures, LP

    Shares: 0.00 · Class: 0.0%

  • Northpond Ventures GP, LLC

    Shares: 0.00 · Class: 0.0%

  • Northpond Ventures II, LP

    Shares: 0.00 · Class: 0.0%

  • Northpond Ventures II GP, LLC

    Shares: 0.00 · Class: 0.0%

  • NPV Listed, LLC

    Shares: 0.00 · Class: 0.0%

  • Northpond Ventures, LLC

    Shares: 0.00 · Class: 0.0%

  • Michael P. Rubin

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001867472-26-000003
Form type
SCHEDULE 13G/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub